This peptide combination is studied in laboratory research for its interaction with growth hormone–releasing hormone (GHRH) and growth hormone secretagogue receptor (GHS‑R) signaling pathways.
CJC‑1295 (No DAC) CAS: 863288‑34‑0
Ipamorelin CAS: 170851‑70‑4
Purity: ≥99% (each component)
Form: Lyophilized powder blend
Intended Use: Laboratory research only
For research purposes only. Not for human or veterinary use.
This peptide combination is studied in laboratory research for its interaction with growth hormone–releasing hormone (GHRH) and growth hormone secretagogue receptor (GHS‑R) signaling pathways.
CJC‑1295 (No DAC) CAS: 863288‑34‑0
Ipamorelin CAS: 170851‑70‑4
Purity: ≥99% (each component)
Form: Lyophilized powder blend
Intended Use: Laboratory research only
For research purposes only. Not for human or veterinary use.